Board & Officers


The ASGCT Board of Directors and the Society's officers have full responsibility for the management, direction and control of the business, policies and affairs of ASGCT, subject only to limitations set forth in the Society's Articles of Incorporation and Bylaws. Learn more about the Board and Officers below.

Paula Cannon, PhD, President

Terence R. Flotte, MD, President-Elect (2024-2025)

Matthew H. Porteus, MD, PhD, Vice President (2024-2027)

Isabelle Riviere, PhD, Secretary

Federico Mingozzi, PhD, Treasurer

At-Large Directors

Aravind Asokan, PhD

Daniel E. Bauer, MD, PhD

Lindsey George, MD

Kimberly Goodspeed, MD, Clinical & Translational Council Chair

Punam Malik, MD, Science + Education Council Chair

Kah-Whye Peng, PhD

Miguel Sena-Esteves, PhD

Jennifer Wellman, MS, Membership Council Chair

Roland W. Herzog, PhD, Ex-Officio

Jeffrey Chamberlain, PhD, Immediate Past President

Bylaws

Read the full Society Bylaws, which were amended and restated in May 2017. 

2024

Advancing Gene and Cell Therapies for Cancer

October 16-17, 2024 | Philadelphia, PA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.